跳至主要内容
临床试验/ACTRN12605000494639
ACTRN12605000494639已完成未知

Impact of HIV infection and treatment with Highly Active Antiretroviral therapy on Reverse Cholesterol Transport

ational Health and Medical Research Council of Australia (grants # 317811 and 317810(DS)0 个研究点目标入组 49 人开始时间: 2005年9月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
Male

入选标准

  • Male patients with HIV infection. 3 groups of 50 patients each. HIV infected patients, naive to ARV therapy and not likely to need to commence therapy for the duration of follow-up (12 months). HIV-infected patients, PI naive, initiating therapy with PI-containing HAART (ARV naïve or NNRTI experienced changing to PI regimen). HIV-infected patients naive to ARV therapy, initiating NNRTI-containing regimen.

排除标准

  • Treatment with any form of lipid lowering drugs, including fish oils. Body Mass Index greater than 27.

研究者

发起方
ational Health and Medical Research Council of Australia (grants # 317811 and 317810(DS)

相似试验